News Results
There are 789,759 News Results
Apr 15, 2024
-- APPLAUSE-IgAN is first and only Phase III study to demonstrate significant proteinuria reduction by targeting the complement system in patients with IgAN(1) -- IgAN is a heterogeneous, progressive, rare...
Apr 16, 2024
BANGALORE, India, April 16, 2024 /PRNewswire/ --
Apr 23, 2024
Michael Carbonara, Tyra Banks, Britto, Randy Fenoli, Original "Love Boat" Cast Members, Celebrity Chefs and TV Personalities on hand to Celebrate Plus Musical Performance by Natasha Bedingfield
Apr 23, 2024
-- XTANDI is now the first and only novel hormone therapy available for the treatment of high-risk biochemical recurrent non-metastatic hormone-sensitive prostate cancer in the European Union (EU) -- XTANDI...
Apr 24, 2024
HALTON REGION, ON, April 24, 2024 /CNW/ - One of the biggest pressures on people right now is housing. Young Canadians are being priced out of their communities. Families are...
Apr 29, 2024
HERCESSI(TM), a biosimilar to Herceptin®, is the first FDA-approved biosimilar from Accord BioPharma, with several more in development
May 2, 2024
New Certified by MongoDB DBaaS program provides cloud infrastructure partners access to the latest MongoDB product features and the ability to offer first-class managed database services to their customers
May 3, 2024
New data from Phase 2b SunRISe-1 study show rapid achievement of complete response (CR) with 98% achieving a CR within 12 weeks
May 3, 2024
Study highlights opportunity for treatment intensification in this population since approximately 50% of patients with high-risk localized prostate cancer (HRLPC) experience disease recurrence within two years of surgery
